Cepralock 2.6 g Intramammary Suspension for Dry Cows

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

ingredients actius:

Bismuth Subnitrate

Disponible des:

MSD Animal Health UK Limited

Codi ATC:

QG52X

Designació comuna internacional (DCI):

Bismuth Subnitrate

formulario farmacéutico:

Intramammary suspension

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cattle

Área terapéutica:

Miscellaneous mechanical teat seal

Estat d'Autorització:

Authorized

Data d'autorització:

2021-04-09

Fitxa tècnica

Revised: November 2023
AN: 01850/2023 & 01851/2023
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cepralock 2.6 g Intramammary Suspension for Dry Cows
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4 g intramammary syringe contains:
ACTIVE SUBSTANCE:
bismuth subnitrate 2.6 g
(equivalent to bismuth 1.9 g)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Intramammary suspension.
White to slightly yellow, homogeneous suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (dairy cows at drying-off).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Prevention of new intramammary infections throughout the dry period.
In cows considered likely to be free of sub-clinical mastitis, the
product can be used
on its own in dry cow management and mastitis control.
4.3
CONTRAINDICATIONS
Do not use the product alone in cows with sub-clinical mastitis at
drying off. Do not
use in cows with clinical mastitis at drying off. Do not use in
lactating cows.See
section 4.7.
Do not use in known cases of hypersensitivity to the active substance
or to any of the
excipients.
Revised: November 2023
AN: 01850/2023 & 01851/2023
Page 2 of 5
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Selection of cows for treatment with the product should be based on
veterinary
clinical judgement. Selection criteria may be based on the mastitis
and cell count
history of individual cows, or recognized tests for the detection of
sub-clinical mastitis
or bacteriological sampling.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
It is good practice to observe dry cows regularly for signs of
clinical mastitis. If a
sealed quarter develops clinical mastitis, the affected quarter should
be stripped out
manually before appropriate therapy is instituted.
To reduce the risk of contamination, do not immerse the syringe in
water.
Use the syringe only once.
It is important to observe strict aseptic technique for the
administration of the product,
because the